Carlos Caldas spends much of his time researching Breast cancer, Cancer, Genetics, Cancer research and Internal medicine. His Breast cancer research includes elements of Human genetics, Bioinformatics and Gene expression profiling. His Cancer study combines topics from a wide range of disciplines, such as Germline mutation, Hereditary diffuse gastric cancer and Carcinoma.
All of his Genetics and Mutation, Gene, Genome, Human genome and DNA Mutational Analysis investigations are sub-components of the entire Genetics study. His biological study spans a wide range of topics, including Missense mutation, Carcinogenesis, Tumor suppressor gene, Metastatic breast cancer and Adenocarcinoma. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Oncology and Pathology.
His primary areas of investigation include Breast cancer, Internal medicine, Cancer research, Cancer and Oncology. In his research on the topic of Breast cancer, Molecular biology is strongly related with Gene. His Internal medicine study frequently draws connections to other fields, such as Gastroenterology.
He has included themes like Carcinogenesis, Cancer cell, Metastatic breast cancer, Transcription factor and PI3K/AKT/mTOR pathway in his Cancer research study. Cancer is a subfield of Genetics that Carlos Caldas investigates. The study incorporates disciplines such as Neoadjuvant therapy, Early breast cancer, Proportional hazards model, Epirubicin and Tissue microarray in addition to Oncology.
His primary scientific interests are in Breast cancer, Cancer research, Internal medicine, Cancer and Oncology. His Breast cancer research integrates issues from Chemotherapy, Somatic cell, Germline, Disease and Computational biology. His Cancer research study incorporates themes from Metastatic breast cancer, Transcription factor, Gene, Exome and PI3K/AKT/mTOR pathway.
His Internal medicine research focuses on Single-nucleotide polymorphism and how it relates to Barrett's esophagus. The concepts of his Cancer study are interwoven with issues in Phenotype, Clinical trial, Gene knockdown and Mutation. His Oncology research is multidisciplinary, relying on both Neoadjuvant therapy, Early breast cancer, Immune system, Estrogen receptor and Circulating tumor DNA.
His primary areas of study are Breast cancer, Cancer research, Cancer, Internal medicine and Oncology. Carlos Caldas specializes in Breast cancer, namely Estrogen receptor. His Cancer research research includes themes of Cisplatin, Transcription factor, Gene, Hyperpolarized carbon-13 MRI and In vivo.
His work deals with themes such as Melanoma, Clinical trial, Computational biology and MEDLINE, which intersect with Cancer. His Hazard ratio, Chemotherapy, Somatic evolution in cancer and Targeted therapy study in the realm of Internal medicine connects with subjects such as Extramural. His Oncology research includes elements of Triple Negative Breast Neoplasms, Biopsy, Surgical specimen, Primary tumor and Survival analysis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov;Serena Nik-Zainal;Serena Nik-Zainal;David C. Wedge;Samuel A. J. R. Aparicio.
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis;Christina Curtis;Sohrab P Shah;Suet-Feung Chin;Gulisa Turashvili.
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
Mario F Fraga;Esteban Ballestar;Ana Villar-Garea;Manuel Boix-Chornet.
Nature Genetics (2005)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson;Dana W Y Tsui;Muhammed Murtaza;Heather Biggs.
The New England Journal of Medicine (2013)
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Sohrab P. Shah;Andrew Roth;Rodrigo Goya;Arusha Oloumi.
International network of cancer genome projects
Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens;Patrick S. Tarpey;Helen Davies;Peter Van Loo;Peter Van Loo.
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza;Sarah-Jane Dawson;Dana W. Y. Tsui;Davina Gale.
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal;Serena Nik-Zainal;Helen Davies;Johan Staaf;Manasa Ramakrishna.
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan;Charles E. Massie;Javier Garcia-Corbacho;Florent Mouliere.
Nature Reviews Cancer (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: